Skip to content

Hepatitis B Vaccine

Published: July 26, 2026Updated: August 29, 2026

The Hepatitis B Surface Antigen Vaccine is an immunization that provides protection against hepatitis B virus infection. The vaccine contains a recombinant protein from the hepatitis B surface antigen that stimulates the immune system to produce protective antibodies. It is recommended for infants, children, and adults at increased risk of hepatitis B exposure, including healthcare workers, individuals with multiple sexual partners, and those traveling to endemic regions.

Quick summary

A vaccine that prevents hepatitis B infection by stimulating the immune system to produce protective antibodies against the hepatitis B virus.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 29, 2026Editorial policy

Key facts at a glance

RxNorm
797752
Generic
Hepatitis B Surface Antigen Vaccine
Class
unclassified
Brands
Twinrix, Heplisav-B, Vaxelis, Prehevbrio, PEDIARIX, Engerix-B, Recombivax
Availability
rx
Lactation
unknown
Routes
—
Forms
prefilled syringe, injection, suspension
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Prevention of hepatitis B virus infection in individuals of all ages. Primary recipients include newborns, infants, children, adolescents, and adults with risk factors such as healthcare work, exposure to blood products, multiple sexual partners, injection drug use, travel to endemic areas, and household contact with infected individuals.

The vaccine contains recombinant hepatitis B surface antigen (HBsAg) protein produced using yeast cells. This protein stimulates the immune system to produce protective antibodies against the hepatitis B virus, conferring active immunity without causing infection. A complete series is required for optimal protection.

Administered as a 2- or 3-dose series depending on the vaccine formulation and recipient age. Common side effects include mild soreness, redness, or swelling at the injection site, and temporary fatigue or headache. The vaccine is contraindicated in individuals with severe allergic reactions to any vaccine component. Blood testing may be recommended after completion of the series to confirm adequate antibody response, particularly in high-risk individuals.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 29, 2026. · Read our editorial policy